The image showcases QuidelOrthos InflammaDry MMP-9 test packaging with a graphic of a blue and purple eye. Text reads, Have confidence in your dry eye diagnosis. A test applicator is displayed beside the box.
A box labeled InflammaDry with an eye graphic and a test strip is shown. The text above reads, Have confidence in your dry eye diagnosis. Company logos QuidelOrtho and InflammaDry are at the bottom on a purple gradient background.

The one-and-only rapid point-of-care test that can detect MMP-9

InflammaDry detects elevated levels of MMP-9, a Key Inflammatory biomarker for ocular surface disease.

A teal-colored, minimalist icon of a maple leaf, commonly associated with Canada. The leaf is centered on a white background and is stylized with clean, geometric lines, resembling the classic shape of a maple leaf.

Complete results in as fast as 10 minutes.

A teal map pin icon with a round head and pointed bottom, set against a white background.

Disposable test, requires just 4 easy steps.

A turquoise horse chess piece, often referred to as a knight, stands facing left against a white background. The design is simple and stylized.

No additional equipment needed to interpret.

Watch Dr. Beck explain the advantages of testing inflammation in the Dry Eye Diagnosis process:

A white Quidel COVID-19 antigen test device on a purple background. The device shows one blue and one red line, indicating a positive test result. The words Control and Test are visible next to the lines.

An optimal treatment pathway for Dry Eye disease.

InflammaDry is the only rapid, in-office CLIA-waived test that detects elevated levels of MMP-9 an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease. InflammaDry accurately identifies patients with oracular surface disease allowing for an optimal treatment pathway.

  • CLIA Waved
  • Results in minutes
  • 4 Simple steps
  • Minimally Invasive
  • Requires no special equipment

Clinical benefits

A person is receiving eye treatment. A hand wearing a blue glove applies white ointment or eye drops to the person’s lower eyelid. The person looks upward, and the background is out of focus.

Pre-surgical

Pre/post-surgical outcomes are improved by identifying and treating patients with dry eye.

A person wearing blue gloves holds a white plastic test device, with labeled control zone and result zone sections. They are inserting a sample using a small tube at the bottom of the device.

Post-surgical

Reduce post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery.

Close-up of two pregnancy tests. The test on the left shows one blue line in the result zone, indicating a negative result. The test on the right shows two blue lines in the result zone, indicating a positive result.

Therapeutic

Therapeutic treatment of dry eye improves patient quality of life.

A split image: On the left, purple text explains how InflammaDry can identify dry eye in four steps—collect sample, assemble test, run test, read results. On the right, an elderly person receives eyedrops from another persons hand.
A healthcare professional administers an eye test to an older woman. Text highlights: InflammaDry accurately identifies patients with dry eye in 4 simple steps. Steps include collecting sample, assembling test, running test, and reading results.

QuidelOrtho

4 products

Showing 1 - 4 of 4 products

Showing 1 - 4 of 4 products
View
The Quidel QuickVue at-home COVID-19 test resembles the InflammaDry MMP-9 test for dry eye diagnosis. Featuring a rectangular display with control and test lines, indicating a positive result, and a branded handle.A white Quidel InflammaDry MMP-9 Testing device against a purple backdrop; dark lines are visible through a small window on the test strip, indicating results for dry eye diagnosis.
Quidel Inflammadry MMP-9 Testing (20-Pack) In-Office Testing In stock
InflammaDry MMP-9 Testing CASE by Quidel, featuring 8 boxes of 20 tests each (160 tests total), is adorned with a vibrant eye image surrounded by swirling water, emphasizing the importance of dry eye diagnosis and ocular health diagnostics.The Quidel InflammaDry MMP-9 Testing CASE packaging features an eye with a tear graphic, highlighting its use in diagnosing dry eyes. It includes 8 boxes of 20 tests each, with two components displayed on a purple background.
Quidel Inflammadry MMP-9 Testing CASE (8 x 20-Packs) 160 Test Total ($180/Box) In stock
The Quidel InflammaDry Control Set on a white background includes three small containers: two with black caps labeled Positive and Negative Control, and one white container labeled Diluent with a dropper cap, essential for detecting MMP-9 protein levels in InflammaDry tests, aiding dry eye diagnosis.Three small bottles on a purple background include a spray bottle labeled Inflamma Diluent and two vials marked InflammaDay Positive Control and InflammaDay Negative Control. These are crucial for diagnosing dry eye by targeting the MMP-9 protein using Quidels Inflammadry technology.
Quidel Quidel Inflammadry Control Set (1 Positive, 1 Negative, and Diluent) In stock
The Quidel QuickVue AdenoViral Conjunctivitis Test (10 Tests) in mainly white packaging with pink accents features three smiling children and the Quidel logo on the top left, perfect for CLIA-waived point-of-care use to quickly diagnose pink eye.The Quidel QuickVue AdenoViral Conjunctivitis Test, designed for CLIA-waived point-of-care use, is a white rectangular device with a Press slider and digital screen displaying results. Ideal for diagnosing adenoviral conjunctivitis such as pink eye, it features the Quidel logo on the handle.
Quidel Quidel QuickVue AdenoViral Conjunctivitis Test (10 Tests) In stock